Search - tctmd.com

Displaying 941 - 960 of 1123

Sort: Relevancy | Date

Presentation BRS 2014

Perspectives on Polymers and Scaffold Design Evolution of DESolve ®

Presenter: Alexandre Abizaid

July 25, 2014

Presentation BRS 2014

Perspectives on Plastic vs Metallic Polymers and Scaffold Properties

Presenter: Ron Waksman

July 25, 2014

Presentation BRS 2014

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB III + IV Clinical Trial Program

Presenter: Gregg W. Stone

July 25, 2014

News Daily News

生物吸收支架表现良好，但是血栓形成引担忧

Todd Neale

July 24, 2014

News Daily News

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Todd Neale

July 24, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

Presentation

GHOST-EU Registry: PCI With Everolimus-Eluting Bioresorbable Vascular Scaffolds in Routine Clinical Practice

Presenter: Davide Capodanno

July 23, 2014

News Industry News

First Patient Enrolled in PROSPECT II Clinical Trial

June 13, 2014

News Industry News

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

June 11, 2014

News Daily News

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

June 04, 2014

News Industry News

Elixir Medical Announces Outstanding Long-term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-approved Novolimus Eluting Coronary Intervention Systems

May 23, 2014

News Industry News

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 21, 2014

News Industry News

NATEC Medical Ltd Receives CE Mark Approval for the Coral CoCr Coronary Stent System

May 16, 2014

News Industry News

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 14, 2014

News Industry News

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

May 13, 2014

News Industry News

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

May 13, 2014

Presentation CIT 2014

Session V: Bioabsorbable scaffold - Will this be the default therapy of the next decade? Bifurcation lesions

Presenter: Antonio Colombo

March 20, 2014

Presentation CIT 2014

Science Behind Bioresorbable Vascular Scaffolds

Presenter: Renu Virmani

March 20, 2014

Presentation CIT 2014

Clinical Outcomes with BRS in Long Lesions and Overlapping Scaffolds

Presenter: P.C. Smits

March 20, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

Advertisement

Perspectives on Polymers and Scaffold Design Evolution of DESolve ®

Perspectives on Plastic vs Metallic Polymers and Scaffold Properties

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB III + IV Clinical Trial Program

生物吸收支架表现良好，但是血栓形成引担忧

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

GHOST-EU Registry: PCI With Everolimus-Eluting Bioresorbable Vascular Scaffolds in Routine Clinical Practice

First Patient Enrolled in PROSPECT II Clinical Trial

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

Elixir Medical Announces Outstanding Long-term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-approved Novolimus Eluting Coronary Intervention Systems

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

NATEC Medical Ltd Receives CE Mark Approval for the Coral CoCr Coronary Stent System

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

Session V: Bioabsorbable scaffold - Will this be the default therapy of the next decade? Bifurcation lesions

Science Behind Bioresorbable Vascular Scaffolds

Clinical Outcomes with BRS in Long Lesions and Overlapping Scaffolds

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content